134 related articles for article (PubMed ID: 27916432)
1. The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change.
Sinnott SJ; Whelton H; Franklin JM; Polinski JM
Health Policy; 2017 Jan; 121(1):27-34. PubMed ID: 27916432
[TBL] [Abstract][Full Text] [Related]
2. Copayments for prescription medicines on a public health insurance scheme in Ireland.
Sinnott SJ; Normand C; Byrne S; Woods N; Whelton H
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):695-704. PubMed ID: 26696242
[TBL] [Abstract][Full Text] [Related]
3. Unintended consequences of a Medicaid prescription copayment policy.
Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
Med Care; 2014 May; 52(5):422-7. PubMed ID: 24686394
[TBL] [Abstract][Full Text] [Related]
4. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.
Domino ME; Martin BC; Wiley-Exley E; Richards S; Henson A; Carey TS; Sleath B
Health Serv Res; 2011 Jun; 46(3):900-19. PubMed ID: 21306363
[TBL] [Abstract][Full Text] [Related]
5. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
Doshi JA; Li P; Desai S; Marcus SC
J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
[TBL] [Abstract][Full Text] [Related]
6. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
Amin K; Farley JF; Maciejewski ML; Domino ME
J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
[TBL] [Abstract][Full Text] [Related]
7. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
Kostova D; Fox J
Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
9. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
[TBL] [Abstract][Full Text] [Related]
10. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
11. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
12. Effect of copayment policies on initial medication non-adherence according to income: a population-based study.
Aznar-Lou I; Pottegård A; Fernández A; Peñarrubia-María MT; Serrano-Blanco A; Sabés-Figuera R; Gil-Girbau M; Fajó-Pascual M; Moreno-Peral P; Rubio-Valera M
BMJ Qual Saf; 2018 Nov; 27(11):878-891. PubMed ID: 29545326
[TBL] [Abstract][Full Text] [Related]
13. Potential bias in medication adherence studies of prevalent users.
Maciejewski ML; Bryson CL; Wang V; Perkins M; Liu CF
Health Serv Res; 2013 Aug; 48(4):1468-86. PubMed ID: 23402554
[TBL] [Abstract][Full Text] [Related]
14. Prescription co-pay reduction program for diabetic employees.
Nair KV; Miller K; Park J; Allen RR; Saseen JJ; Biddle V
Popul Health Manag; 2010 Oct; 13(5):235-45. PubMed ID: 20879904
[TBL] [Abstract][Full Text] [Related]
15. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
Kennedy J; Morgan S
Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
[TBL] [Abstract][Full Text] [Related]
16. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
17. Effect of a medication copayment increase in veterans with schizophrenia.
Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
[TBL] [Abstract][Full Text] [Related]
18. Copayments for medications after June 30, 2010. Final rule.
Department of Veterans Affairs
Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
[TBL] [Abstract][Full Text] [Related]
19. Who bears the burden of Medicaid drug copayment policies?
Stuart B; Zacker C
Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
[TBL] [Abstract][Full Text] [Related]
20. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
Manteuffel M; Williams S; Chen W; Verbrugge RR; Pittman DG; Steinkellner A
J Womens Health (Larchmt); 2014 Feb; 23(2):112-9. PubMed ID: 24206025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
